Pre-order Enquiry
Request Free Sample
Global Amyotrophic Lateral Sclerosis Treatment Market 2019-2023
SKU ID : TNV-13792997 | Publishing Date : 28-Dec-2018 | No. of pages : 103
Request Sample
Request Customization
Check Discounts
About this market
Initiatives to increase R&D for new amyotrophic lateral sclerosis therapies will boost the growth of the market. This increase in R&D for new amyotrophic lateral sclerosis therapies is due to the increase in number of cases of amyotrophic lateral sclerosis. analysts have predicted that the amyotrophic lateral sclerosis treatment market will register a CAGR of almost 20% by 2023.
Market Overview
Increase in incidence and prevalence of ALS
The incidence and prevalence of amyotrophic lateral sclerosis is increasing. Amyotrophic lateral sclerosis is commonly known as Lou Gehrig's disease. which is a progressive and fatal neuromuscular disease for which a cure is yet to be identified. The hereditary form of amyotrophic lateral sclerosis is known as familial amyotrophic lateral sclerosis. and it occurs in 5% to 10% of the cases.
Patent expiry of drugs
Loss of patents and market exclusivity of drugs create opportunities for the sales of low-cost alternative drugs, which may decrease the sales of approved drugs. Currently. the market has two drugs, which can delay the progression of the disease and are approved for the treatment of amyotrophic lateral sclerosis.
For the detailed list of factors that will drive and challenge the growth of the amyotrophic lateral sclerosis treatment market during the 2019-2023, view our report.
Competitive Landscape
The market appears to be fragmented and with the presence of several companies including Mitsubishi Tanabe Pharma and Sanofi the competitive environment is quite intense. Factors such as initiatives to increase R&D for new amyotrophic lateral sclerosis therapies and the increase in incidence and prevalence of ALS, will provide considerable growth opportunities to amyotrophic lateral sclerosis treatment manufactures. ITALFARMACO, Mitsubishi Tanabe Pharma, and Sanofi are some of the major companies covered in this report.
Initiatives to increase R&D for new amyotrophic lateral sclerosis therapies will boost the growth of the market. This increase in R&D for new amyotrophic lateral sclerosis therapies is due to the increase in number of cases of amyotrophic lateral sclerosis. analysts have predicted that the amyotrophic lateral sclerosis treatment market will register a CAGR of almost 20% by 2023.
Market Overview
Increase in incidence and prevalence of ALS
The incidence and prevalence of amyotrophic lateral sclerosis is increasing. Amyotrophic lateral sclerosis is commonly known as Lou Gehrig's disease. which is a progressive and fatal neuromuscular disease for which a cure is yet to be identified. The hereditary form of amyotrophic lateral sclerosis is known as familial amyotrophic lateral sclerosis. and it occurs in 5% to 10% of the cases.
Patent expiry of drugs
Loss of patents and market exclusivity of drugs create opportunities for the sales of low-cost alternative drugs, which may decrease the sales of approved drugs. Currently. the market has two drugs, which can delay the progression of the disease and are approved for the treatment of amyotrophic lateral sclerosis.
For the detailed list of factors that will drive and challenge the growth of the amyotrophic lateral sclerosis treatment market during the 2019-2023, view our report.
Competitive Landscape
The market appears to be fragmented and with the presence of several companies including Mitsubishi Tanabe Pharma and Sanofi the competitive environment is quite intense. Factors such as initiatives to increase R&D for new amyotrophic lateral sclerosis therapies and the increase in incidence and prevalence of ALS, will provide considerable growth opportunities to amyotrophic lateral sclerosis treatment manufactures. ITALFARMACO, Mitsubishi Tanabe Pharma, and Sanofi are some of the major companies covered in this report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
